Yesterday, Consol Bozzo Mulet, Scientific & Regulatory Affairs Director at ASPHALION, and Daniel Langa García, Senior Regulatory Affairs Officer at Asphalion, gave a training session on regulatory approach of “ICH Q12: Control de cambios. Consideraciones técnicas y regulatorias en el ciclo de vida de los productos farmacéuticos.”.
The training was organized by Institut de Formació Contínua IL3 – Universitat de Barcelona (UB) and coordinated by Rafael Beaus, Global Consultancy Manager at Telstar.
Ricard Andreu Saumell, Scientific & Regulatory Affairs Officer at Asphalion, attended this training session and said: “there are still many questions to be clarified, but it has been a pleasure to be able to attend this training and discuss the actual landscape of the guideline.“
